FinnGen 人群规模免疫多组学图谱揭示调控性疾病的遗传机制
Population-scale immune multiome atlas reveals regulatory disease mechanisms
FinnGen 项目发布人群规模免疫单核多组学图谱,产出单核 caQTL、eQTL 与 peak–gene 连锁汇总统计并公开于 finngen.fi,可通过 CASCADE 交互浏览。
Data availability
The FinnGen single-nucleus caQTL, eQTL, peak–gene link summary statistics generated in this study are publicly available at https://www.finngen.fi/en/access_results and interactively browsable at https://cascade.finngen.fi/. The FinnGen GWAS summary statistics (R12) are available at https://r12.finngen.fi/. The KANTA lab value GWAS summary statistics are available at https://labvalues.finngen.fi/. The FinnGen (R12) + MVP + UKBB meta-analysis results are available at https://mvp-ukbb.finngen.fi/. Individual-level data, including single-nucleus count matrices, are available to approved researchers. FinnGen as a research project is granted use of national healthcare data and biospecimens according to national (Finland’s Act on the Secondary Use of Health and Social Data) and European (the General Data Protection Regulation) regulations, which preclude the research project from distributing individual-level data. Those wishing to work with individual-level data can apply through three independent channels. Health register data are requested from Findata (https://findata.fi/en/). Individual-level genotype and other profiling data generated by the project from Finnish biobanks are requested through the Fingenious portal operated by the Finnish Biobank Cooperative (https://site.fingenious.fi/en/). The Blood Service Biobank is not a member of the Finnish Biobank Cooperative, and its materials, including the individual-level single-nucleus multiome data generated in this study, are requested directly from biopankki@bloodservice.fi. Academic users wishing instead to collaborate with the FinnGen project directly can fill in a collaboration request form at https://www.finngen.fi/en/how-we-collaborate. Other enquiries should be addressed to finngen-info@helsinki.fi and receive a response within 2 weeks. Data use is governed by the permit or agreement granted by the relevant authority in each case. Analyses of individual-level data are performed within FinnGen’s secure computing environment by a researcher affiliated with the project, and access to that environment is not granted to external collaborators. The BBJ GWAS summary statistics33,64 are available online (https://pheweb.jp/) and at the National Bioscience Database Center (NBDC) Human Database (accession code: hum0197; https://humandbs.dbcls.jp/en/research/hum0197). The Japan COVID-19 Task Force whole-blood eQTL summary statistics65 are available online (https://japan-omics.jp/) and at the NBDC Human Database (accession code: hum0343; https://humandbs.dbcls.jp/en/research/hum0343). Moreover, the following datasets were obtained and reanalysed in this study: eQTL Catalogue15 (https://www.ebi.ac.uk/eqtl/); TenK10K20 (https://doi.org/10.5281/zenodo.17474112)130; SingleBrain23 (https://doi.org/10.5281/zenodo.14907598)131; Chinese Immune Multi-Omics Atlas21 (https://db.cngb.org/trueblood/cima/); Alzheimer’s disease GWAS meta-analysis from ref. 55, GWAS Catalog (accession code: GCST90027158; https://www.ebi.ac.uk/gwas/studies/GCST90027158); MPRA data from ref. 7 (https://doi.org/10.5281/zenodo.15297964)132. All analyses used the human genome assembly GRCh38 (NCBI: GCA_000001405.15), with multiome sequencing data aligned to the 10x Genomics Cell Ranger ARC GRCh38 reference (refdata-cellranger-arc-GRCh38-2020-A, https://www.10xgenomics.com/support/software/cell-ranger-arc/downloads). Additional reference resources include GENCODE121 v.39 (https://www.gencodegenes.org/human/release_39.html); Ensembl Variant Effect Predictor120 v.105 (https://ftp.ensembl.org/pub/release-105/); gnomAD v.3 Gnocchi non-coding constraint61 and v.4.1 gene constraint62 (https://gnomad.broadinstitute.org/downloads); ENCODE4 registry of cCREs38 (https://screen.wenglab.org/downloads).
Code availability
Our single-cell processing pipelines and analysis workflows are available at GitHub (https://github.com/FINNGEN/singlecell-pipeline)133. The code to generate the figures is available at GitHub (https://github.com/mkanai/finngen-multiome-flagship)134. The CASCADE framework is available at GitHub (https://github.com/mkanai/cascade)135. The fasthurdle package for efficient hurdle model computation is available at GitHub (https://github.com/mkanai/fasthurdle)136. The ldcov package for efficient covariate-adjusted LD computation is available at GitHub (https://github.com/mkanai/ldcov)137. FinnGen’s standard analysis workflows are available as follows: GWAS (https://github.com/FINNGEN/regenie-pipelines)138; fine-mapping (https://github.com/FINNGEN/finemapping-pipeline)139; colocalization (https://github.com/FINNGEN/coloc.susie.direct)140; KANTA preprocessing and QC (https://github.com/FINNGEN/kanta_lab_preprocessing)141.
References
Maurano, M. T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190–1195 (2012).
ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).
Cuomo, A. S. E., Nathan, A., Raychaudhuri, S., MacArthur, D. G. & Powell, J. E. Single-cell genomics meets human genetics. Nat. Rev. Genet. 24, 535–549 (2023).
Kang, J. B., Raveane, A., Nathan, A., Soranzo, N. & Raychaudhuri, S. Methods and insights from single-cell expression quantitative trait loci. Annu. Rev. Genom. Hum. Genet. 24, 277–303 (2023).
Mu, Z. et al. Impact of disease-associated chromatin accessibility QTLs across immune cell types and contexts. Cell Genom. 6, 101061 (2026).
Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508–518 (2023).
Siraj, L. et al. Functional dissection of complex trait variants at single-nucleotide resolution. Nature https://doi.org/10.1038/s41586-026-10121-6 (2026).
Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016).
Mostafavi, H., Spence, J. P., Naqvi, S. & Pritchard, J. K. Systematic differences in discovery of genetic effects on gene expression and complex traits. Nat. Genet. 55, 1866–1875 (2023).
Connally, N. J. et al. The missing link between genetic association and regulatory function. eLife 11, e74970 (2022).
Võsa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300–1310 (2021).
Abdellaoui, A., Yengo, L., Verweij, K. J. H. & Visscher, P. M. 15 years of GWAS discovery: realizing the promise. Am. J. Hum. Genet. 110, 179–194 (2023).
Schaid, D. J., Chen, W. & Larson, N. B. From genome-wide associations to candidate causal variants by statistical fine-mapping. Nat. Rev. Genet. 19, 491–504 (2018).
The GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318–1330 (2020).
Kerimov, N. et al. A compendium of uniformly processed human gene expression and splicing quantitative trait loci. Nat. Genet. 53, 1290–1299 (2021).
Kumasaka, N., Knights, A. J. & Gaffney, D. J. Fine-mapping cellular QTLs with RASQUAL and ATAC-seq. Nat. Genet. 48, 206–213 (2016).
Tehranchi, A. et al. Fine-mapping cis-regulatory variants in diverse human populations. eLife 8, e39595 (2019).
Yazar, S. et al. Single-cell eQTL mapping identifies cell type-specific genetic control of autoimmune disease. Science 376, eabf3041 (2022).
Kock, K. H. et al. Asian diversity in human immune cells. Cell 188, 2288–2306 (2025).
Cuomo, A. S. E. et al. Impact of rare and common genetic variation on cell type-specific gene expression in human blood. Preprint at medRxiv https://doi.org/10.1101/2025.03.20.25324352 (2025).
Yin, J. et al. Chinese Immune Multi-Omics Atlas. Science 391, eadt3130 (2026).
Varshney, A. et al. Population-scale skeletal muscle single-nucleus multi-omic profiling reveals extensive context specific genetic regulation. Preprint at bioRxiv https://doi.org/10.1101/2023.12.15.571696 (2024).
Jang, B. et al. A meta-analysis of single-nucleus expression quantitative trait loci linking genetic risk to brain disorders. Nat. Genet. 58, 737–747 (2026).
Chun, S. et al. Limited statistical evidence for shared genetic effects of eQTLs and autoimmune-disease-associated loci in three major immune-cell types. Nat. Genet. 49, 600–605 (2017).
Yao, D. W., O’Connor, L. J., Price, A. L. & Gusev, A. Quantifying genetic effects on disease mediated by assayed gene expression levels. Nat. Genet. 52, 626–633 (2020).
Jeong, R. & Bulyk, M. L. Chromatin accessibility variation provides insights into missing regulation underlying immune-mediated diseases. eLife 13, RP98289 (2025).
Benaglio, P. et al. Mapping genetic effects on cell type-specific chromatin accessibility and annotating complex immune trait variants using single nucleus ATAC-seq in peripheral blood. PLoS Genet. 19, e1010759 (2023).
Chen, S., Lake, B. B. & Zhang, K. High-throughput sequencing of the transcriptome and chromatin accessibility in the same cell. Nat. Biotechnol. 37, 1452–1457 (2019).
Sakaue, S. et al. Tissue-specific enhancer-gene maps from multimodal single-cell data identify causal disease alleles. Nat. Genet. 56, 615–626 (2024).
Mitra, S. et al. Single-cell multi-ome regression models identify functional and disease-associated enhancers and enable chromatin potential analysis. Nat. Genet. 56, 627–636 (2024).
Liu, H. et al. Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants. Science 387, eadp4753 (2025).
Arthur, T. D. et al. Multiomic QTL mapping reveals phenotypic complexity of GWAS loci and prioritizes putative causal variants. Cell Genom. 5, 100775 (2025).
Kanai, M. et al. Insights from complex trait fine-mapping across diverse populations. Preprint at medRxiv https://doi.org/10.1101/2021.09.03.21262975 (2021).
Taylor, D. J. et al. Sources of gene expression variation in a globally diverse human cohort. Nature 632, 122–130 (2024).
Honkanen, J. et al. Blood donor biobank pipeline to collect genome-based samples for research. Sci. Rep. 16, 10202 (2026).
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 (2021).
Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
Moore, J. E. et al. An expanded registry of candidate cis-regulatory elements. Nature https://doi.org/10.1038/s41586-025-09909-9 (2026).
Zhou, W. et al. Efficient and accurate mixed model association tool for single-cell eQTL analysis. Preprint at medRxiv https://doi.org/10.1101/2024.05.15.24307317 (2024).
Taylor-Weiner, A. et al. Scaling computational genomics to millions of individuals with GPUs. Genome Biol. 20, 228 (2019).
Nagai, A. et al. Overview of the BioBank Japan Project: study design and profile. J. Epidemiol. 27, S2–S8 (2017).
Alasoo, K. et al. Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response. Nat. Genet. 50, 424–431 (2018).
Urbut, S. M., Wang, G., Carbonetto, P. & Stephens, M. Flexible statistical methods for estimating and testing effects in genomic studies with multiple conditions. Nat. Genet. 51, 187–195 (2019).
Reeve, M. P. et al. Genome-wide association analyses of autoimmune hypothyroidism reveal autoimmune and thyroid-specific contributions and an inverse relationship with cancer risk. Nat. Genet. 58, 550–559 (2026).
Siggs, O. M., Li, X., Xia, Y. & Beutler, B. ZBTB1 is a determinant of lymphoid development. J. Exp. Med. 209, 19–27 (2012).
Lukic, S., Nicolas, J.-C. & Levine, A. J. The diversity of zinc-finger genes on human chromosome 19 provides an evolutionary mechanism for defense against inherited endogenous retroviruses. Cell Death Differ. 21, 381–387 (2014).
Robertson, C. C. et al. Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes. Nat. Genet. 53, 962–971 (2021).
Javierre, B. M. et al. Lineage-specific genome architecture links enhancers and non-coding disease variants to target gene promoters. Cell 167, 1369–1384 (2016).
Thakore, P. I. et al. BACH2 regulates diversification of regulatory and proinflammatory chromatin states in TH17 cells. Nat. Immunol. 25, 1395–1410 (2024).
Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016).
Yamamoto, M. et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668–6672 (2002).
Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T. & Seya, T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4, 161–167 (2003).
Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301, 640–643 (2003).
Gu, Y. et al. RhoH GTPase recruits and activates Zap70 required for T cell receptor signaling and thymocyte development. Nat. Immunol. 7, 1182–1190 (2006).
Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat. Genet. 54, 412–436 (2022).
Shiratori, I., Ogasawara, K., Saito, T., Lanier, L. L. & Arase, H. Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor. J. Exp. Med. 199, 525–533 (2004).
Zhou, Y. et al. Human early-onset dementia caused by DAP12 deficiency reveals a unique signature of dysregulated microglia. Nat. Immunol. 24, 545–557 (2023).
Martiskainen, H. et al. Monoallelic TYROBP deletion is a novel risk factor for Alzheimer’s disease. Mol. Neurodegener. 20, 50 (2025).
Haure-Mirande, J.-V., Audrain, M., Ehrlich, M. E. & Gandy, S. Microglial TYROBP/DAP12 in Alzheimer’s disease: transduction of physiological and pathological signals across TREM2. Mol. Neurodegener. 17, 55 (2022).
Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434–443 (2020).
Chen, S. et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625, 92–100 (2024).
Guez, J. et al. Integrating 730,947 exome sequences with clinical literature improves gene discovery. Preprint at medRxiv https://doi.org/10.64898/2026.03.23.26349081 (2026).
Liu, K. et al. Sensitive transcriptomics and genotyping reveals function of genetic variants in immunity. Preprint at bioRxiv https://doi.org/10.1101/2025.03.12.642879 (2025).
Sakaue, S. et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat. Genet. 53, 1415–1424 (2021).
Wang, Q. S. et al. The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force. Nat. Commun. 13, 4830 (2022).
Lechner, M. G. et al. Clonally expanded, thyrotoxic effector CD8+ T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis. Sci. Transl. Med. 15, eadg0675 (2023).
Wang, X. & Goldstein, D. B. Enhancer domains predict gene pathogenicity and inform gene discovery in complex disease. Am. J. Hum. Genet. 106, 215–233 (2020).
Zuin, J. et al. Nonlinear control of transcription through enhancer-promoter interactions. Nature 604, 571–577 (2022).
Naqvi, S. et al. Precise modulation of transcription factor levels identifies features underlying dosage sensitivity. Nat. Genet. 55, 841–851 (2023).
Osterwalder, M. et al. Enhancer redundancy provides phenotypic robustness in mammalian development. Nature 554, 239–243 (2018).
Einarsson, H. et al. Promoter sequence and architecture determine expression variability and confer robustness to genetic variants. eLife 11, e80943 (2022).
Lehner, B. Selection to minimise noise in living systems and its implications for the evolution of gene expression. Mol. Syst. Biol. 4, 170 (2008).
Brümmer, A. & Bergmann, S. Disentangling genetic effects on transcriptional and post-transcriptional gene regulation through integrating exon and intron expression QTLs. Nat. Commun. 15, 3786 (2024).
Loh, P.-R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet. 48, 1443–1448 (2016).
Browning, B. L. & Browning, S. R. Genotype imputation with millions of reference samples. Am. J. Hum. Genet. 98, 116–126 (2016).
Voss, E. A. et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J. Am. Med. Inform. Assoc. 22, 553–564 (2015).
Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).
Fleming, S. J. et al. Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender. Nat. Methods 20, 1323–1335 (2023).
Kang, H. M. et al. Multiplexed droplet single-cell RNA-sequencing using natural genetic variation. Nat. Biotechnol. 36, 89–94 (2018).
Li, B. et al. Cumulus provides cloud-based data analysis for large-scale single-cell and single-nucleus RNA-seq. Nat. Methods 17, 793–798 (2020).
Clarke, Z. A. & Bader, G. D. MALAT1 expression indicates cell quality in single-cell RNA sequencing data. Preprint at bioRxiv https://doi.org/10.1101/2024.07.14.603469 (2024).
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
Virshup, I., Rybakov, S., Theis, F. J., Angerer, P. & Wolf, F. A. anndata: access and store annotated data matrices. J. Open Source Softw. 9, 4371 (2024).
Stuart, T., Srivastava, A., Madad, S., Lareau, C. A. & Satija, R. Single-cell chromatin state analysis with Signac. Nat. Methods 18, 1333–1341 (2021).
Fulco, C. P. et al. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat. Genet. 51, 1664–1669 (2019).
Corces, M. R. et al. The chromatin accessibility landscape of primary human cancers. Science 362, eaav1898 (2018).
Granja, J. M. et al. ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. Nat. Genet. 53, 403–411 (2021).
van de Geijn, B., McVicker, G., Gilad, Y. & Pritchard, J. K. WASP: allele-specific software for robust molecular quantitative trait locus discovery. Nat. Methods 12, 1061–1063 (2015).
Wilson, P. C. et al. Multimodal single cell sequencing implicates chromatin accessibility and genetic background in diabetic kidney disease progression. Nat. Commun. 13, 5253 (2022).
Zhang, K., Zemke, N. R., Armand, E. J. & Ren, B. A fast, scalable and versatile tool for analysis of single-cell omics data. Nat. Methods 21, 217–227 (2024).
Van den Berge, K., Soneson, C., Robinson, M. D. & Clement, L. stageR: a general stage-wise method for controlling the gene-level false discovery rate in differential expression and differential transcript usage. Genome Biol. 18, 151 (2017).
Walters, M. C. et al. Enhancers increase the probability but not the level of gene expression. Proc. Natl Acad. Sci. USA 92, 7125–7129 (1995).
Rossi, F. M., Kringstein, A. M., Spicher, A., Guicherit, O. M. & Blau, H. M. Transcriptional control: rheostat converted to on/off switch. Mol. Cell 6, 723–728 (2000).
Fukaya, T., Lim, B. & Levine, M. Enhancer control of transcriptional bursting. Cell 166, 358–368 (2016).
Bartman, C. R., Hsu, S. C., Hsiung, C. C.-S., Raj, A. & Blobel, G. A. Enhancer regulation of transcriptional bursting parameters revealed by forced chromatin looping. Mol. Cell 62, 237–247 (2016).
Larsson, A. J. M. et al. Genomic encoding of transcriptional burst kinetics. Nature 565, 251–254 (2019).
Stegle, O., Parts, L., Piipari, M., Winn, J. & Durbin, R. Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses. Nat. Protoc. 7, 500–507 (2012).
Xue, A., Yazar, S., Neavin, D. & Powell, J. E. Pitfalls and opportunities for applying latent variables in single-cell eQTL analyses. Genome Biol. 24, 33 (2023).
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
Liu, Y. et al. ACAT: a fast and powerful p value combination method for rare-variant analysis in sequencing studies. Am. J. Hum. Genet. 104, 410–421 (2019).
Ongen, H., Buil, A., Brown, A. A., Dermitzakis, E. T. & Delaneau, O. Fast and efficient QTL mapper for thousands of molecular phenotypes. Bioinformatics 32, 1479–1485 (2016).
Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA 100, 9440–9445 (2003).
Article ADS MathSciNet CAS PubMed PubMed Central Google Scholar
Fairfax, B. P. et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343, 1246949 (2014).
Nédélec, Y. et al. Genetic ancestry and natural selection drive population differences in immune responses to pathogens. Cell 167, 657–669 (2016).
Quach, H. et al. Genetic adaptation and Neandertal admixture shaped the immune system of human populations. Cell 167, 643–656 (2016).
Kim-Hellmuth, S. et al. Genetic regulatory effects modified by immune activation contribute to autoimmune disease associations. Nat. Commun. 8, 266 (2017).
Schmiedel, B. J. et al. Impact of genetic polymorphisms on human immune cell gene expression. Cell 175, 1701–1715 (2018).
Randolph, H. E. et al. Genetic ancestry effects on the response to viral infection are pervasive but cell type specific. Science 374, 1127–1133 (2021).
Soskic, B. et al. Immune disease risk variants regulate gene expression dynamics during CD4+ T cell activation. Nat. Genet. 54, 817–826 (2022).
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 53, 1097–1103 (2021).
Wang, G., Sarkar, A., Carbonetto, P. & Stephens, M. A simple new approach to variable selection in regression, with application to genetic fine mapping. J. R. Stat. Soc. Ser. B 82, 1273–1300 (2020).
Benner, C. et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493–1501 (2016).
Lovell, M. C. A simple proof of the FWL theorem. J. Econ. Educ. 39, 88–91 (2008).
Karczewski, K. J. et al. Pan-UK Biobank genome-wide association analyses enhance discovery and resolution of ancestry-enriched effects. Nat. Genet. 57, 2408–2417 (2025).
Wallace, C. A more accurate method for colocalisation analysis allowing for multiple causal variants. PLoS Genet. 17, e1009440 (2021).
Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).
Kanai, M. et al. Meta-analysis fine-mapping is often miscalibrated at single-variant resolution. Cell Genom. 2, 100210 (2022).
McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 122 (2016).
Mudge, J. M. et al. GENCODE 2025: reference gene annotation for human and mouse. Nucleic Acids Res. 53, D966–D975 (2025).
Hormozdiari, F. et al. Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits. Nat. Genet. 50, 1041–1047 (2018).
Gazal, S. et al. Linkage disequilibrium-dependent architecture of human complex traits shows action of negative selection. Nat. Genet. 49, 1421–1427 (2017).
Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).
Hujoel, M. L. A., Gazal, S., Hormozdiari, F., van de Geijn, B. & Price, A. L. Disease heritability enrichment of regulatory elements is concentrated in elements with ancient sequence age and conserved function across species. Am. J. Hum. Genet. 104, 611–624 (2019).
Zeng, T., Spence, J. P., Mostafavi, H. & Pritchard, J. K. Bayesian estimation of gene constraint from an evolutionary model with gene features. Nat. Genet. 56, 1632–1643 (2024).
Kulakovskiy, I. V. et al. HOCOMOCO: a comprehensive collection of human transcription factor binding sites models. Nucleic Acids Res. 41, D195–D202 (2013).
Coetzee, S. G., Coetzee, G. A. & Hazelett, D. J. motifbreakR: an R/Bioconductor package for predicting variant effects at transcription factor binding sites. Bioinformatics 31, 3847–3849 (2015).
Coetzee, S. G. & Hazelett, D. J. motifbreakR v2: expanded variant analysis including indels and integrated evidence from transcription factor binding databases. Bioinform. Adv. 4, vbae162 (2024).
Cuomo, A. S. E. Data from: Impact of rare and common genetic variation on cell type-specific gene expression in human blood. Zenodo https://doi.org/10.5281/zenodo.18221260 (2026).
Jang, B., Won, H.-H. & Raj, T. SingleBrain: Single-nucleus expression QTL meta-analysis summary statistics across multiple human brain cohorts. Zenodo https://doi.org/10.5281/zenodo.14908182 (2025).
Siraj, L. et al. Functional dissection of complex and molecular trait variants at single nucleotide resolution. Zenodo https://doi.org/10.5281/zenodo.15297965 (2025).
Kanai, M. Singlecell-Pipeline: single-nucleus multiome processing and QTL discovery in FinnGen. Zenodo https://doi.org/10.5281/zenodo.21979830 (2026).
Kanai, M. Analysis code for the FinnGen single-nucleus multiome atlas flagship manuscript. Zenodo https://doi.org/10.5281/zenodo.21982484 (2026).
Kanai, M. Cascade: comprehensive analysis suite for cell-type specificity and accessibility-driven QTL effects. Zenodo https://doi.org/10.5281/zenodo.21925418 (2026).
Kanai, M. Fasthurdle: fast implementation of hurdle models. Zenodo https://doi.org/10.5281/zenodo.21932524 (2026).
Kanai, M. Ldcov: efficient linkage disequilibrium calculation with covariate adjustment. Zenodo https://doi.org/10.5281/zenodo.21934451 (2026).
Mehtonen, J. et al. Regenie-Pipelines: WDL pipelines for running Regenie in FinnGen. Zenodo https://doi.org/10.5281/zenodo.21934767 (2026).
Kanai, M. et al. Finemapping-Pipeline: statistical fine-mapping pipeline in FinnGen. Zenodo https://doi.org/10.5281/zenodo.21934770 (2026).
Lehisto, A., Zheng, Z. & Kanai, M. Coloc.susie.direct: colocalization of SuSiE fine-mapping credible sets in FinnGen. Zenodo https://doi.org/10.5281/zenodo.21933710 (2026).
della Briotta Parolo, P. & Llorens, V. Kanta_lab_preprocessing: preprocessing and quality control of KANTA laboratory values in FinnGen. Zenodo https://doi.org/10.5281/zenodo.21938287 (2026).
Acknowledgements
We thank the blood donors and the staff of the Finnish Red Cross Blood Service for their help in sample collection; the members of Xavier and Daly laboratories for their feedback; and H. Kang for her editorial assistance. We acknowledge the participants and investigators of FinnGen and BioBank Japan. Generative AI tools (Claude, Anthropic; Codex, OpenAI) were used for language editing and for assistance with software development and verification of analysis code. All scientific content and conclusions are the sole responsibility of the authors.
Funding
This work was supported by funding from the National Institutes of Health for methods development (DK043351 to R.J.X.; DK062432 to R.J.X. and M.J.D.), the Klarman Cell Observatory (to R.J.X.) and sundry funds from the Department of Molecular Biology at MGH (to R.J.X.). M. Kanai was supported by the Masason Foundation; W.Z. by the National Human Genome Research Institute of the National Institutes of Health under award numbers R00HG012222 and R01HG014518; Y.O. by JSPS KAKENHI (25H01057) and AMED (JP24km0405217, JP24ek0109594, JP24ek0410113, JP24kk0305022, JP223fa627001, JP223fa627002, JP223fa627010, JP223fa627011, JP22zf0127008, JP24tm0524002, JP24wm0625504 and JP24gm1810011), JST Moonshot R&D (JPMJMS2021 and JPMJMS2024), Ono Pharmaceutical Foundation for Oncology, Immunology and Neurology, Baelz Research Grant, RIKEN TRIP initiative (AGIS); the BioBank Japan Project by the Tailor-Made Medical Treatment program of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), and the Japan Agency for Medical Research and Development (AMED). The FinnGen project is funded by two grants from Business Finland (HUS 4685/31/2016 and UH 4386/31/2016) and the following industry partners: AbbVie, AstraZeneca UK, Biogen MA, Bristol Myers Squibb (and Celgene Corporation & Celgene International II), Genentech, Merck Sharp & Dohme, Pfizer, GlaxoSmithKline Intellectual Property Development, Sanofi US Services, Maze Therapeutics, Johnson & Johnson Innovative Medicine, Novartis, Boehringer Ingelheim International and Bayer. The following biobanks are acknowledged for delivering biobank samples to FinnGen: Auria Biobank (www.auria.fi/biopankki), THL Biobank (www.thl.fi/biobank), Helsinki Biobank (www.helsinginbiopankki.fi), Biobank Borealis of Northern Finland (https://www.ppshp.fi/Tutkimus-ja-opetus/Biopankki/Pages/Biobank-Borealis-briefly-in-English.aspx), Finnish Clinical Biobank Tampere (www.tays.fi/en-US/Research_and_development/Finnish_Clinical_Biobank_Tampere), Biobank of Eastern Finland (www.ita-suomenbiopankki.fi/en), Central Finland Biobank (www.ksshp.fi/fi-FI/Potilaalle/Biopankki), Finnish Red Cross Blood Service Biobank (www.veripalvelu.fi/verenluovutus/biopankkitoiminta), Terveystalo Biobank (www.terveystalo.com/fi/Yritystietoa/Terveystalo-Biopankki/Biopankki/) and Arctic Biobank (https://www.oulu.fi/en/university/faculties-and-units/faculty-medicine/northern-finland-birth-cohorts-and-arctic-biobank). All Finnish Biobanks are members of BBMRI.fi infrastructure (https://www.bbmri-eric.eu/national-nodes/finland/). Finnish Biobank Cooperative—FINBB (https://finbb.fi/) is the coordinator of BBMRI-ERIC operations in Finland. The Finnish biobank data can be accessed through the Fingenious services (https://site.fingenious.fi/en/) managed by FINBB. This work is also supported by the FinnGen project for the costs of sample collection and single-cell sequencing.
Author information
Author notes
These authors jointly supervised this work: Mark J. Daly, Ramnik J. Xavier
Authors and Affiliations
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Masahiro Kanai, Juha Karjalainen, Georgia Panagiotaropoulou, Yuanxiang Zhang, Zhili Zheng, Mark J. Daly, Mary Pat Reeve, Mary Pat Reeve, Mitja Kurki, Wei Zhou, Aarno Palotie & Mark J. Daly
Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA, USA
Masahiro Kanai, Georgia Panagiotaropoulou, Yuanxiang Zhang, Kosaku Nanki, Toshimi Yoshida, Kai Liu, Daniel B. Graham & Ramnik J. Xavier
Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA
Masahiro Kanai, Kosaku Nanki, Toshimi Yoshida, Kai Liu, Daniel B. Graham & Ramnik J. Xavier
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
Masahiro Kanai, Rodosthenis S. Rodosthenous, Juha Karjalainen, Yuanxiang Zhang, Sanni Ruotsalainen, Zhili Zheng, Mark J. Daly, Rodosthenis S. Rodosthenous, Mary Pat Reeve, Mary Pat Reeve, Mitja Kurki, Wei Zhou, Aarno Palotie & Mark J. Daly
Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Toni M. Delorey, Shane Murphy, Isabella Teixeira-Soldano, Hee Seung Hwang, Cristin McCabe, Eric Chen, Marla Glean, Nitya Mehrotra, Emily P. Finan, Daniel Chafamo, Yixiao Zhu, Caroline B. M. Porter, Orr Ashenberg & Ramnik J. Xavier
Blood Service Biobank, Finnish Red Cross Blood Service, Vantaa, Finland
Jarno Honkanen, Julianna Juvila, Jussi Halonen, Kimmo Pitkänen & Jukka Partanen
Program in Infectious Disease and Microbiome, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Georgia Panagiotaropoulou, Yuanxiang Zhang, Kosaku Nanki, Toshimi Yoshida, Kai Liu, Daniel B. Graham & Ramnik J. Xavier
Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
Georgia Panagiotaropoulou, Yuanxiang Zhang, Zhili Zheng, Mark J. Daly, Mitja Kurki & Mark J. Daly
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Georgia Panagiotaropoulou, Yuanxiang Zhang, Zhili Zheng, Mark J. Daly, Mitja Kurki, Wei Zhou, Aarno Palotie & Mark J. Daly
Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland
Mikko Arvas & Jukka Partanen
Department of Genome Informatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Yoshihiko Tomofuji, Daiki Tokuyasu, Shinichi Namba, Kyuto Sonehara & Yukinori Okada
Laboratory for Systems Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
Yoshihiko Tomofuji, Shinichi Namba, Kyuto Sonehara & Yukinori Okada
Department of Neurology, Keio University School of Medicine, Tokyo, Japan
Daiki Tokuyasu
Laboratory of Statistical Immunology, Immunology Frontier Research Center (WPI-IFReC), The University of Osaka, Suita, Japan
Yukinori Okada
Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe), The University of Osaka, Suita, Japan
Yukinori Okada
Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
Wei Zhou & Aarno Palotie
Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Ramnik J. Xavier
Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Koichi Matsuda, Takayuki Morisaki, Natsuhiko Kumasaka & Akiko Nagai
Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
Koichi Matsuda, Takayuki Morisaki & Akiko Nagai
Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan
Norihiro Harada & Sonoko Harada
Atopy (Allergy) Research Center, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan
Sonoko Harada
Department of Hematology, Nippon Medical School, Tokyo, Japan
Yasunobu Nagata, Satoshi Wakita & Hiroki Yamaguchi
AbbVie, Chicago, IL, USA
Bridget Riley-Gillis, Howard Jacob, Jeffrey Waring, Bridget Riley-Gillis, Fedik Rahimov, Adam Ziemann, Nizar Smaoui, Anne Lehtonen, Apinya Lertratanakul, Relja Popovic, Mengzhen Liu, Anneke Den Hollander, Jan Freudenberg, Britney Milkovich, Andrew Blumenfeld & Tushar Kumar
AstraZeneca, Cambridge, UK
Coralie Viollet, Slavé Petrovski, Ioanna Tachmazidou, Dirk Paul, Bram Prins, Eleanor Wheeler, Kousik Kundu, Santosh Atanur, Andrew Lowe, Thomas Spargo, Oliver Burren & Margarete Fabre
Bayer, Leverkusen, Germany
Alix Berton, Santha Ramakrishnan, Fabio Baschiera, Hans van Leeuwen, Himanshu Manchanda, Karl Heilbron, Martin Rao, Nicole Schmidt, Samu Kurki, Johanna Mielke, Juho Immonen, Thomas Battram & Tobias Hogrebe
Biogen, Cambridge, MA, USA
Ellen Tsai, Susan Eaton, Ketian Yu, Stephanie Loomis & Coro Paisan-Ruiz
Boehringer Ingelheim, Ingelheim am Rhein, Germany
Zhihao Ding, Marc Jung, Hanati Tuoken, Elke Markert, Frank Li, Yao Hu, Christoph Ogris, Eric Simon, Julio Cesar Bolivar Lopez & Monika Frysz
Bristol Myers Squibb, New York, NY, USA
Emily Holzinger, Robert Plenge, Joseph Maranville, Shameek Biswas, Benjamin Sun, Marla Hochfeld, Cara Carty, Michael Turchin, Neelakshi Jog, Corneliu Bodea, Janie Shelton, Chen Li, Kritika Singh, Peng Jiang, Stephanie Loomis, Elena Sanchez, Lilith Moss, Zijie Zhao & Anna Podgornaia
Genentech, San Francisco, CA, USA
Mark McCarthy, Rion Pendergrass, Natalie Bowers, Edmond Teng, Tim Lu, Hubert Chen, Jennifer Schutzman, Erich Strauss, Hao Chen, David Choy, Brian Yaspan, Cameron Adams, Michael Rothenberg, Sergio Dellepiane, Anubha Mahajan, Michael Holmes, Diana Chang & Tushar Bhangale
GlaxoSmithKline, Collegeville, PA, USA
Jonathan Davitte, Janet Kumar, Charli Harlow, Lea Sarow-Blat, Diana L. Cousminer, Jagtar Nijjar, Jessica Chao, Michal Magid, Shashank Jariwala, Chris Floyd, Dan Swerdlow, Erding Hu, Prerak Desai, Stephen Haddad, Damien Croteau-Chonka, Billy Fahy & Paola Bronson
Merck, Kenilworth, NJ, USA
Chia-Yen Chen, Neha Raghavan, Jae-Hoon Sul, Jason Miller, Fabiana Farias, Andrey Loboda, Jorge Del-Aguila, Elisabeth Vollmann, Jozsef Karman, Julie Fiore, Rajesh Kamath, Andrei Popescu, Delphine Fagegaltier, Travis Barr, Aristide Merola, Oliver Freeman & Simonne Longerich
Pfizer, New York, NY, USA
Melis Atalar Aksit, Anna Vlahiotis, Xinli Hu, Kirsi Kalpala, Melissa Miller, Nan Bing, Jaakko Parkkinen, Heli Lehtonen, Stefan McDonough, Ying Wu, Erin Macdonald-Dunlop, Jessica Chung, Michael McLean, Joshua Chiou, Hye In Kim, Sivakumar Pitchumani, Sumedha Jassal & Madhurima Saxena
Translational Sciences, Sanofi R&D, Framingham, MA, USA
Katherine Klinger, Clement Chatelain, Jorg Blankenstein, Catherine O’Riordan, Samuel Lessard, Suzanne Jacobs, Hamid Mattoo, David Habiel & Guanling Huan
Maze Therapeutics, San Francisco, CA, USA
Karol Estrada, Robert Graham, Sahar Mozaffari & Christopher DeBoever
Johnson & Johnson Innovative Medicine, Spring House, PA, USA
Dawn Waterworth, Karen He, Ekaterina Khramtsova, Amy Hart, Meijian Guan, Alessandro Porello, P. Dunnmon, Sara Gale, Brice Keyes, John Kwon, Jonathan Sherlock, Matt Loza, Chris Whelan, W. Galpern, Yanfei Zhang, Mona Selej & Abolfazl Doostparast Torshizi
Novartis Institutes for BioMedical Research, Cambridge, MA, USA
Chris O’Donnell, Nicole Renaud, Ma’en Obeidat, Jonathan Chung, Jonas Zierer, Mari Niemi, Enrico Ferrero, Nikos Patsopoulos, Nancy Finkel, Sabina Pfister, Shola Richards, Katherine McCauley, Xiaobo Xia & Mike Mendelson
HiLIFE, University of Helsinki, Helsinki, Finland
Tomi P. Mäkelä
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
Jaakko Kaprio, Samuli Ripatti, Felix Vaura, Nina Mars, Esa Pitkänen, Hannele Laivuori, Katja Kivinen, Elisabeth Widen, Taru Tukiainen, Hanna Ollila, Elmo Saarentaus, Anne Kerola, Eero Vuoksimaa, Joni Lindbohm, Zhiyu Yang, Matthew Sampson, Adrian Banerji, Michelle McNulty, Aoxing Liu, Joel Rämö, Austin Argentieri, Amanda Elliott, Anu Jalanko, Risto Kajanne, Mervi Aavikko, Helen Cooper, Denise Öller, Tarja Laitinen, Auli Toivola, Pietro Della Briotta Parolo, Arto Lehisto, Juha Mehtonen, Reza Jabal, Mutaamba Maasha, Samuel Jones, Raymond Walters, Paavo Häppölä, L. Elisa Lahtela, Johanna Paltta, Juulia Partanen, Mari Kaunisto, Elina Kilpeläinen, Tianduanyi Wang, Timo P. Sipilä, Oluwaseun Alexander Dada, Awaisa Ghazal, Rigbe Weldatsadik, Jaska Uimonen, Kati Donner, Susanna Lemmelä, Shanmukha Sampath Padmanabhuni, Marika Kaakinen, Shuang Luo, Vincent Llorens, Dawit Yohannes & Iina Laak
Arctic Biobank, Oulu, Finland
Minna Ruddock
University of Oulu, Oulu, Finland
Minna Ruddock, Teija Kekonen, Raisa Serpi, Reetta Hinttala, Johannes Kettunen, Heidi Silven, Eeva Sliz, Riikka Arffman, Susanna Savukoski, Riitta Kaarteenaho & Jaakko Tyrmi
Auria Biobank, Turku, Finland
Lila Kallio, Antti Hakanen & Johanna Schleutker
University of Turku, Turku, Finland
Lila Kallio, Antti Hakanen, Johanna Schleutker, Laura Kuusalo, Laura Pirilä, Tapio Hellman, Matti Vuori, Teemu Niiranen & Johanna Paltta
Wellbeing Services County of Southwest Finland, Turku, Finland
Lila Kallio, Antti Hakanen, Johanna Schleutker, Laura Pirilä, Juha Rinne, Roosa Kallionpää, Markku Voutilainen, Antti Palomäki, Riitta Lahesmaa, Kaj Metsärinne, Jenni Aittokallio, Klaus Elenius, Sirkku Peltonen, Leena Koulu, Ulvi Gursoy, Varpu Jokimaa & Tytti Willberg
THL Biobank, Helsinki, Finland
Terhi Kilpi, Markus Perola, Tiina Wahlfors, Päivi Laiho, Teemu Paajanen, Arto Pietilä & Aki Havulinna
Finnish Institute for Health and Welfare (THL), Helsinki, Finland
Terhi Kilpi, Markus Perola, Tiina Wahlfors, Veikko Salomaa, Jaana Suvisaari, Teemu Niiranen, Päivi Laiho, Teemu Paajanen, Arto Pietilä & Aki Havulinna
Helsinki Biobank, Helsinki, Finland
Taneli Raivio, Eero Punkka, Olli Carpén & Anu Loukola
Helsinki University and Hospital District of Helsinki and Uusimaa, Helsinki, Finland
Taneli Raivio, Eero Punkka, Olli Carpén & Anu Loukola
Northern Finland Biobank Borealis, Oulu, Finland
Teija Kekonen, Raisa Serpi, Reetta Hinttala & Johannes Kettunen
Wellbeing Services County of North Ostrobothnia, Oulu, Finland
Teija Kekonen, Raisa Serpi, Reetta Hinttala, Johannes Kettunen, Timo Blomster, Johanna Huhtakangas, Terttu Harju, Kaisa Tasanen, Laura Huilaja, Vuokko Anttonen, Marja Vääräsmäki, Outi Uimari, Laure Morin-Papunen, Maarit Niinimäki & Terhi Piltonen
Finnish Clinical Biobank Tampere, Tampere, Finland
Kati Kristiansson, Sanna Siltanen & Mika Kähönen
University of Tampere, Tampere, Finland
Kati Kristiansson, Sanna Siltanen, Mika Kähönen, Jaakko Tyrmi, Harri Siirtola & Javier Gracia-Tabuenca
Wellbeing Services County of Pirkanmaa, Tampere, Finland
Kati Kristiansson, Sanna Siltanen, Mika Kähönen, Jukka Peltola, Airi Jussila, Katri Kaukinen, Pia Isomäki, Jussi Hernesniemi, Annika Auranen, Hannu Uusitalo, Teea Salmi, Venla Kurra, Laura Kotaniemi-Talonen & Argyro Bizaki-Vallaskangas
Biobank of Eastern Finland, Kuopio, Finland
Veli-Matti Kosma, Arto Mannermaa & Hanna Kujala
University of Eastern Finland, Kuopio, Finland
Veli-Matti Kosma, Arto Mannermaa, Hanna Kujala, Pirkko Pussinen, Mikko Hiltunen & Eino Solje
Wellbeing Services County of North Savo, Kuopio, Finland
Veli-Matti Kosma, Arto Mannermaa, Hanna Kujala, Valtteri Julkunen, Reetta Kälviäinen, Hilkka Soininen, Mikko Kiviniemi, Oili Kaipiainen-Seppänen, Margit Pelkonen, Päivi Auvinen, Maria Siponen, Liisa Suominen, Päivi Mäntylä & Kai Kaarniranta
Central Finland Biobank, Jyväskylä, Finland
Jari Laukkanen & Tiina Jokela
University of Jyväskylä, Jyväskylä, Finland
Jari Laukkanen, Tiina Jokela & Eija Laakkonen
Wellbeing Services County of Central Finland, Jyväskylä, Finland
Jari Laukkanen & Tiina Jokela
Finnish Biobank Cooperative—FINBB, Turku, Finland
Mervi Ahlroth, Johanna Mäkelä, Johanna Mäkelä, Pauli Wihuri, Tom Southerington & Meri Lähteenmäki
Business Finland, Helsinki, Finland
Outi Tuovila
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
Katriina Aalto-Setälä
Estonian Biobank, Tartu, Estonia
Triin Laisk & Natalia Pujol
Finnish Red Cross Blood Service, Helsinki, Finland
Satu Koskela & Jouni Lauronen
Finnish Hematology Registry and Clinical Biobank, Helsinki, Finland
Satu Koskela & Jouni Lauronen
Helsinki University Central Hospital, Helsinki, Finland
Kristiina Aittomäki
Helsinki University Hospital and University of Helsinki, Helsinki, Finland
Pirkko Pussinen, Tuomo Meretoja, Heikki Joensuu, Peeter Karihtala, Emma Juuri, Aino Salminen, Tuula Salo, David Rice, Pekka Nieminen, Ulla Palotie, Fredrik Åberg, Daniel Gordin, Patrik Finne, Joni A. Turunen & Sanna Toppila-Salmi
Hospital District of Helsinki and Uusimaa, Helsinki, Finland
Daniel Gordin, Minna Raivio, Pentti Tienari, Martti Färkkilä, Jukka Koskela, Sampsa Pikkarainen, Kari Eklund, Paula Kauppi, Juha Sinisalo, Marja-Riitta Taskinen, Tiinamaija Tuomi, Timo Hiltunen, Johanna Mattson, Eveliina Salminen, Terhi Ollila, Katariina Hannula-Jouppi, Oskari Heikinheimo, Ilkka Kalliala, Lauri Aaltonen, Erkki Isometsä, Antti Aarnisalo, Ilkka Immonen, Salla Ranta & Filip Scheperjans
Folkhälsan Research Center, Helsinki, Finland
Joni A. Turunen
Harvard Medical School, Boston, MA, USA
Matthew Sampson, Adrian Banerji & Michelle McNulty
Broad Institute, Cambridge, MA, USA
Matthew Sampson, Adrian Banerji, Michelle McNulty, Aoxing Liu, Joel Rämö, Austin Argentieri, Amanda Elliott, Reza Jabal, Mutaamba Maasha & Raymond Walters
Massachusetts General Hospital, Boston, MA, USA
Amanda Elliott
Northern Ostrobothnia Hospital District, Oulu, Finland
Elisa Rahikkala
Oulu University Hospital and University of Oulu, Oulu, Finland
Kirsi Sipilä
University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland
Valtteri Julkunen, Ville Leinonen & Sanna Toppila-Salmi
University of Gothenburg, Gothenburg, Sweden
Hannu Kankaanranta
Seinäjoki Central Hospital, Seinäjoki, Finland
Hannu Kankaanranta
Tampere University, Tampere, Finland
Hannu Kankaanranta
University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Antti Mäkitie
University of Helsinki, Helsinki, Finland
Iiris Hovatta, Niko Välimäki, Minttu Marttila, Anne Portaankorva & Sofia Kuitunen
University of Lodz, Lodz, Poland
Kai Kaarniranta
GlaxoSmithKline, Brentford, UK
Fanli Xu, Laura Addis, John Eicher, Linda McCarthy, Jorge Esparza Gordillo, Joanna Betts, Rajashree Mishra, Audrey Chu & Diptee Kulkarni
GlaxoSmithKline, Espoo, Finland
Kirsi Auro
GlaxoSmithKline, Stevenage, UK
David Pulford
Janssen-Cilag Oy, Espoo, Finland
Sauli Vuoti
Johnson & Johnson Innovative Medicine, Boston, MA, USA
Dermot Reilly
Johnson & Johnson Innovative Medicine, Titusville, NJ, USA
Qingqin S. Li
Novartis, Basel, Switzerland
Majd Mouded & Debby Ngo
Authors
- Masahiro Kanai
- Toni M. Delorey
- Jarno Honkanen
- Rodosthenis S. Rodosthenous
- Julianna Juvila
- Shane Murphy
- Isabella Teixeira-Soldano
- Hee Seung Hwang
- Juha Karjalainen
- Jussi Halonen
- Georgia Panagiotaropoulou
- Yuanxiang Zhang
- Cristin McCabe
- Eric Chen
- Kosaku Nanki
- Toshimi Yoshida
- Kai Liu
- Marla Glean
- Nitya Mehrotra
- Emily P. Finan
- Daniel Chafamo
- Yixiao Zhu
- Mikko Arvas
- Sanni Ruotsalainen
- Zhili Zheng
- Yoshihiko Tomofuji
- Daiki Tokuyasu
- Shinichi Namba
- Kyuto Sonehara
- Yukinori Okada
- Mary Pat Reeve
- Mitja Kurki
- Caroline B. M. Porter
- Orr Ashenberg
- Wei Zhou
- Kimmo Pitkänen
- Jukka Partanen
- Aarno Palotie
- Daniel B. Graham
- Mark J. Daly
- Ramnik J. Xavier
Consortia
BioBank Japan Project
- Koichi Matsuda
- , Takayuki Morisaki
- , Yukinori Okada
- , Natsuhiko Kumasaka
- , Akiko Nagai
- , Shinichi Namba
- , Norihiro Harada
- , Sonoko Harada
- , Yasunobu Nagata
- , Satoshi Wakita
- & Hiroki Yamaguchi
FinnGen
Steering Committee
- Aarno Palotie
- , Mark J. Daly
Pharmaceutical companies
- Bridget Riley-Gillis
- , Howard Jacob
- , Coralie Viollet
- , Slavé Petrovski
- , Alix Berton
- , Santha Ramakrishnan
- , Ellen Tsai
- , Zhihao Ding
- , Emily Holzinger
- , Robert Plenge
- , Joseph Maranville
- , Mark McCarthy
- , Rion Pendergrass
- , Jonathan Davitte
- , Chia-Yen Chen
- , Melis Atalar Aksit
- , Anna Vlahiotis
- , Katherine Klinger
- , Clement Chatelain
- , Jorg Blankenstein
- , Karol Estrada
- , Robert Graham
- , Dawn Waterworth
- , Chris O’Donnell
- & Nicole Renaud
University of Helsinki and Biobanks
- Tomi P. Mäkelä
- , Jaakko Kaprio
- , Minna Ruddock
- , Lila Kallio
- , Antti Hakanen
- , Terhi Kilpi
- , Markus Perola
- , Jukka Partanen
- , Taneli Raivio
- , Eero Punkka
- , Teija Kekonen
- , Raisa Serpi
- , Kati Kristiansson
- , Sanna Siltanen
- , Veli-Matti Kosma
- , Arto Mannermaa
- , Jari Laukkanen
- , Tiina Jokela
- , Mervi Ahlroth
- & Johanna Mäkelä
Other Experts/Non-Voting Members
- Outi Tuovila
Scientific Committee
Pharmaceutical companies
- Jeffrey Waring
- , Bridget Riley-Gillis
- , Fedik Rahimov
- , Ioanna Tachmazidou
- , Slavé Petrovski
- , Alix Berton
- , Santha Ramakrishnan
- , Ellen Tsai
- , Zhihao Ding
- , Marc Jung
- , Hanati Tuoken
- , Shameek Biswas
- , Benjamin Sun
- , Rion Pendergrass
- , Jonathan Davitte
- , Neha Raghavan
- , Jae-Hoon Sul
- , Melis Atalar Aksit
- , Xinli Hu
- , Katherine Klinger
- , Robert Graham
- , Dawn Waterworth
- , Nicole Renaud
- , Ma’en Obeidat
- , Jonathan Chung
- , Jonas Zierer
- & Mari Niemi
University of Helsinki and Biobanks
- Samuli Ripatti
- , Johanna Schleutker
- , Markus Perola
- , Tiina Wahlfors
- , Mikko Arvas
- , Olli Carpén
- , Reetta Hinttala
- , Johannes Kettunen
- , Arto Mannermaa
- , Katriina Aalto-Setälä
- , Mika Kähönen
- , Jari Laukkanen
- & Johanna Mäkelä
Clinical Group/Task Force
- Hanna Kujala
- , Triin Laisk
- , Natalia Pujol
- , Mika Kähönen
- , Veikko Salomaa
- , Jaana Suvisaari
- , Satu Koskela
- , Jouni Lauronen
- , Kristiina Aittomäki
- , Pirkko Pussinen
- , Tuomo Meretoja
- , Heikki Joensuu
- , Peeter Karihtala
- , Emma Juuri
- , Aino Salminen
- , Tuula Salo
- , David Rice
- , Pekka Nieminen
- , Ulla Palotie
- , Fredrik Åberg
- , Daniel Gordin
- , Patrik Finne
- , Joni A. Turunen
- , Minna Raivio
- , Pentti Tienari
- , Martti Färkkilä
- , Jukka Koskela
- , Sampsa Pikkarainen
- , Kari Eklund
- , Paula Kauppi
- , Juha Sinisalo
- , Marja-Riitta Taskinen
- , Tiinamaija Tuomi
- , Timo Hiltunen
- , Johanna Mattson
- , Eveliina Salminen
- , Terhi Ollila
- , Katariina Hannula-Jouppi
- , Oskari Heikinheimo
- , Ilkka Kalliala
- , Lauri Aaltonen
- , Erkki Isometsä
- , Antti Aarnisalo
- , Ilkka Immonen
- , Salla Ranta
- , Filip Scheperjans
- , Felix Vaura
- , Nina Mars
- , Esa Pitkänen
- , Hannele Laivuori
- , Katja Kivinen
- , Elisabeth Widen
- , Taru Tukiainen
- , Hanna Ollila
- , Elmo Saarentaus
- , Anne Kerola
- , Eero Vuoksimaa
- , Joni Lindbohm
- , Zhiyu Yang
- , Matthew Sampson
- , Adrian Banerji
- , Michelle McNulty
- , Aoxing Liu
- , Joel Rämö
- , Austin Argentieri
- , Amanda Elliott
- , Elisa Rahikkala
- , Kirsi Sipilä
- , Valtteri Julkunen
- , Ville Leinonen
- , Sanna Toppila-Salmi
- , Mikko Hiltunen
- , Eino Solje
- , Hannu Kankaanranta
- , Antti Mäkitie
- , Iiris Hovatta
- , Niko Välimäki
- , Minttu Marttila
- , Anne Portaankorva
- , Eija Laakkonen
- , Heidi Silven
- , Eeva Sliz
- , Riikka Arffman
- , Susanna Savukoski
- , Riitta Kaarteenaho
- , Jaakko Tyrmi
- , Laura Kuusalo
- , Laura Pirilä
- , Tapio Hellman
- , Matti Vuori
- , Teemu Niiranen
- , Timo Blomster
- , Johanna Huhtakangas
- , Terttu Harju
- , Kaisa Tasanen
- , Laura Huilaja
- , Vuokko Anttonen
- , Marja Vääräsmäki
- , Outi Uimari
- , Laure Morin-Papunen
- , Maarit Niinimäki
- , Terhi Piltonen
- , Reetta Kälviäinen
- , Hilkka Soininen
- , Mikko Kiviniemi
- , Oili Kaipiainen-Seppänen
- , Margit Pelkonen
- , Päivi Auvinen
- , Maria Siponen
- , Liisa Suominen
- , Päivi Mäntylä
- , Kai Kaarniranta
- , Jukka Peltola
- , Airi Jussila
- , Katri Kaukinen
- , Pia Isomäki
- , Jussi Hernesniemi
- , Annika Auranen
- , Hannu Uusitalo
- , Teea Salmi
- , Venla Kurra
- , Laura Kotaniemi-Talonen
- , Argyro Bizaki-Vallaskangas
- , Juha Rinne
- , Roosa Kallionpää
- , Markku Voutilainen
- , Antti Palomäki
- , Riitta Lahesmaa
- , Kaj Metsärinne
- , Jenni Aittokallio
- , Klaus Elenius
- , Sirkku Peltonen
- , Leena Koulu
- , Ulvi Gursoy
- , Varpu Jokimaa
- , Tytti Willberg
- , Adam Ziemann
- , Nizar Smaoui
- , Anne Lehtonen
- , Apinya Lertratanakul
- , Relja Popovic
- , Mengzhen Liu
- , Anneke Den Hollander
- , Jan Freudenberg
- , Britney Milkovich
- , Andrew Blumenfeld
- , Tushar Kumar
- , Dirk Paul
- , Bram Prins
- , Eleanor Wheeler
- , Kousik Kundu
- , Santosh Atanur
- , Andrew Lowe
- , Thomas Spargo
- , Oliver Burren
- , Margarete Fabre
- , Fabio Baschiera
- , Hans van Leeuwen
- , Himanshu Manchanda
- , Karl Heilbron
- , Martin Rao
- , Nicole Schmidt
- , Samu Kurki
- , Johanna Mielke
- , Juho Immonen
- , Thomas Battram
- , Tobias Hogrebe
- , Susan Eaton
- , Ketian Yu
- , Stephanie Loomis
- , Coro Paisan-Ruiz
- , Elke Markert
- , Frank Li
- , Yao Hu
- , Christoph Ogris
- , Eric Simon
- , Julio Cesar Bolivar Lopez
- , Monika Frysz
- , Marla Hochfeld
- , Cara Carty
- , Michael Turchin
- , Neelakshi Jog
- , Corneliu Bodea
- , Janie Shelton
- , Chen Li
- , Kritika Singh
- , Peng Jiang
- , Stephanie Loomis
- , Elena Sanchez
- , Lilith Moss
- , Zijie Zhao
- , Anna Podgornaia
- , Natalie Bowers
- , Edmond Teng
- , Tim Lu
- , Hubert Chen
- , Jennifer Schutzman
- , Erich Strauss
- , Hao Chen
- , David Choy
- , Rion Pendergrass
- , Brian Yaspan
- , Cameron Adams
- , Mark McCarthy
- , Michael Rothenberg
- , Rion Pendergrass
- , Sergio Dellepiane
- , Anubha Mahajan
- , Michael Holmes
- , Anubha Mahajan
- , Diana Chang
- , Tushar Bhangale
- , Fanli Xu
- , Laura Addis
- , John Eicher
- , Linda McCarthy
- , Jorge Esparza Gordillo
- , Joanna Betts
- , Rajashree Mishra
- , Audrey Chu
- , Diptee Kulkarni
- , Janet Kumar
- , Charli Harlow
- , Lea Sarow-Blat
- , Diana L. Cousminer
- , Jagtar Nijjar
- , Jessica Chao
- , Michal Magid
- , Shashank Jariwala
- , Chris Floyd
- , Dan Swerdlow
- , Erding Hu
- , Prerak Desai
- , Stephen Haddad
- , Damien Croteau-Chonka
- , Billy Fahy
- , Paola Bronson
- , Kirsi Auro
- , David Pulford
- , Sauli Vuoti
- , Dermot Reilly
- , Karen He
- , Ekaterina Khramtsova
- , Amy Hart
- , Meijian Guan
- , Alessandro Porello
- , P. Dunnmon
- , Sara Gale
- , Brice Keyes
- , John Kwon
- , Jonathan Sherlock
- , Matt Loza
- , Chris Whelan
- , W. Galpern
- , Yanfei Zhang
- , Mona Selej
- , Abolfazl Doostparast Torshizi
- , Qingqin S. Li
- , Sahar Mozaffari
- , Christopher DeBoever
- , Jason Miller
- , Fabiana Farias
- , Andrey Loboda
- , Jorge Del-Aguila
- , Elisabeth Vollmann
- , Jozsef Karman
- , Julie Fiore
- , Rajesh Kamath
- , Andrei Popescu
- , Delphine Fagegaltier
- , Travis Barr
- , Aristide Merola
- , Oliver Freeman
- , Simonne Longerich
- , Enrico Ferrero
- , Nikos Patsopoulos
- , Nancy Finkel
- , Sabina Pfister
- , Shola Richards
- , Katherine McCauley
- , Xiaobo Xia
- , Mike Mendelson
- , Majd Mouded
- , Debby Ngo
- , Kirsi Kalpala
- , Melissa Miller
- , Nan Bing
- , Jaakko Parkkinen
- , Heli Lehtonen
- , Stefan McDonough
- , Ying Wu
- , Erin Macdonald-Dunlop
- , Jessica Chung
- , Michael McLean
- , Joshua Chiou
- , Hye In Kim
- , Sivakumar Pitchumani
- , Sumedha Jassal
- , Madhurima Saxena
- , Catherine O’Riordan
- , Samuel Lessard
- , Suzanne Jacobs
- , Hamid Mattoo
- , David Habiel
- & Guanling Huan
Biobank directors
- Lila Kallio
- , Tiina Wahlfors
- , Jukka Partanen
- , Eero Punkka
- , Raisa Serpi
- , Sanna Siltanen
- , Veli-Matti Kosma
- & Tiina Jokela
FinnGen Teams
Administration
- Anu Jalanko
- , Risto Kajanne
- , Mervi Aavikko
- , Helen Cooper
- , Denise Öller
- , Tarja Laitinen
- & Sofia Kuitunen
Sample and data logistics
- Auli Toivola
- & Rodosthenis S. Rodosthenous
Analysis
- Mitja Kurki
- , Juha Karjalainen
- , Pietro Della Briotta Parolo
- , Arto Lehisto
- , Juha Mehtonen
- , Reza Jabal
- , Mutaamba Maasha
- , Sanni Ruotsalainen
- , Samuel Jones
- , Raymond Walters
- & Paavo Häppölä
Disease Task Forces
- L. Elisa Lahtela
- , Johanna Paltta
- & Juulia Partanen
Communication
- Mari Kaunisto
Sandbox and Cloud Services
- Elina Kilpeläinen
- , Tianduanyi Wang
- , Timo P. Sipilä
- , Oluwaseun Alexander Dada
- , Awaisa Ghazal
- , Rigbe Weldatsadik
- & Jaska Uimonen
Genotyping
- Kati Donner
Sample Collection Coordination
- Anu Loukola
Sample Logistics
- Päivi Laiho
Registry Data Operations
- Susanna Lemmelä
- , Teemu Paajanen
- , Arto Pietilä
- & Aki Havulinna
Phenotype team
- Mary Pat Reeve
- , Shanmukha Sampath Padmanabhuni
- , Harri Siirtola
- , Javier Gracia-Tabuenca
- , Marika Kaakinen
- , Shuang Luo
- , Vincent Llorens
- & Dawit Yohannes
Data protection officer
- Iina Laak
FINBB—Finnish Biobank Cooperative
- Mervi Ahlroth
- , Johanna Mäkelä
- , Pauli Wihuri
- , Tom Southerington
- & Meri Lähteenmäki
Contributions
M. Kanai, A.P., D.B.G., M.J.D. and R.J.X. conceived and designed the study. J. Honkanen, R.S.R., J.J., J. Halonen, M.A., K.P. and J.P. coordinated sample collection at the Finnish Red Cross Blood Service. T.M.D., S.M., I.T.-S., C.M., K.N., T.Y., K.L., M.G., N.M. and E.P.F. performed single-cell experiments. M. Kanai, H.S.H., E.C., D.C., Y. Zhu and C.B.M.P. processed multiome data. M. Kanai, R.S.R., J.K., G.P., Y. Zhang, S.R., Z.Z., M.P.R., M. Kurki, O.A. and W.Z. performed statistical analyses. M. Kanai developed the CASCADE framework, software and interactive browser. M. Kanai, Y.T., D.T., S.N., K.S. and Y.O. performed the BioBank Japan replication analyses. M.J.D. and R.J.X. jointly supervised the study. M. Kanai, D.B.G., M.J.D. and R.J.X. wrote the manuscript. All of the authors read, revised and approved the final manuscript.
Corresponding authors
Correspondence to Mark J. Daly or Ramnik J. Xavier.
Ethics declarations
Competing interests
R.J.X. is board director at MoonLake Immunotherapeutics, a consultant to Nestlé and a member of the scientific advisory board at Magnet Biomedicine. M.J.D. is a founder of Maze Therapeutics. The other authors declare no competing interests.
Peer review
Peer review information
Nature thanks Yuriy Baglaenko, Bradley Harris, and Lan Jiang, who co-reviewed with Guochao Li, for their contribution to the peer review of this work. Peer reviewer reports are available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data figures and tables
Extended Data Fig. 1 Schematic overview of experimental and computational pipelines.
a, Sample processing workflow. Peripheral blood mononuclear cells (PBMCs) from 1,171 donors were processed to generate paired single-nucleus RNA sequencing (snRNA-seq) and single-nucleus assay for transposase-accessible chromatin sequencing (snATAC-seq) data. Created in BioRender. Kanai, M. (2026) https://BioRender.com/9mpuxyf. b, Multiome analysis pipeline. Counts under each box indicate the number of nuclei entering each step, whereas counts on arrows indicate nuclei flowing along that path. The snRNA-seq atlas contains 10,612,211 nuclei from 1,108 donors, and the snATAC-seq atlas contains 7,100,899 nuclei from 1,093 donors with paired snRNA-seq data. QC, quality control. eQTL, expression quantitative trait locus.
Extended Data Fig. 2 Regulatory hotspots at gene clusters with extensive peak–gene links.
Extensive peak–gene links were observed at 19p13.11 containing gene clusters (a, JUND, UBA52, and IFI30) and 8p21.3 containing TRAIL receptors (b, TNFRSF10A–D). The top heatmap represents co-accessibility of peaks in this region with significant Pearson correlation (FDR < 0.05; Methods). The middle panel represents the density of peaks linked to each target gene, representing regulatory hotspots of each gene. The bottom panel represents significant peak–gene links with target genes, where colour represents effect sizes of links and the y-axis represents the corresponding absolute value.
Extended Data Fig. 3 Genetic architecture of molQTLs at fine-grained cell types.
a,d, The number of significant cis-eGenes (a) and cis-caPeaks (d) for each level 2 (L2) cell type (FDR < 0.05; Methods). Colour represents the number of cell types that each eGene or caPeak is significantly detected for. b,e, The number of cis-eGenes (b) and cis-caPeaks (e) with fine-mapped 95% CSs. Colour represents the number of 95% CSs for each cis-eGene or cis-caPeak. c,f, Colocalization rates of cis-eQTL CSs (c) and cis-caQTL CSs (f) between level 1 (L1) and L2 cell types. Colour represents the colocalization rate. The x- and y-axes in both panels were aligned based on the heatmap clustering in eQTLs (c) for direct comparison. g–i, The relationship between the number of cis-eGenes (g), caPeaks (h), and tested genes or peaks (i) and the number of nuclei per sample. Colour represents different L1 cell types and shape represents either caQTL or eQTL.
Extended Data Fig. 4 Method benchmarking and functional characterization of fine-mapped molQTL variants.
a, Comparison of the number of cis-eGenes between SAIGE-QTL and tensorQTL (ACAT FDR < 0.05; Methods). The blue line is a linear fit through the origin and the grey band is its 95% confidence interval, whereas the dotted slope represents y = x. b, LocusZoom plot of the cis-eQTL association for LILRB4 expression in monocytes and the cis-pQTL association for LILRB4 protein levels in plasma. A lead variant, rs776736, is shown as a diamond. Colour represents r2 to the lead variant. Horizontal dotted line represents the genome-wide significance threshold (P < 5.0 × 10−8). P values are two-sided, from cis-eQTL or cis-pQTL association tests. c,d, The distribution of fine-mapped caQTL (c) or eQTL (d) variants around the peak summit or transcription start site (TSS), respectively. Instead of density shown in Fig. 2g, distance to peak summit or TSS is binned by 10 kb. e,f, Functional enrichment of high-PIP (>0.9) caQTL or eQTL variants, stratified by cCRE status for coding variants (e) or the regulatory mode of their overlapping peak (f, dual, switch/rheostat alternating, exclusively switch, or exclusively rheostat). Enrichment is defined as a risk ratio of being fine-mapped and being in an annotation (Methods). Error bars represent 95% confidence intervals.
Extended Data Fig. 5 CASCADE classification framework.
a, Classification scheme showing 25 mutually exclusive patterns based on i) chromatin accessibility (CA) peak overlap, ii) caQTL, iii) peak–gene links, and iv) eQTL, grouped into seven mechanistic categories (Methods). b, Sankey diagram of the QTL mechanism classifications of 16,477 fine-mapped eQTL variants (PIP > 0.5). For each layer, nodes represent proportions of those variants. Edges between nodes in each layer represent the fraction of variants shared between nodes. c,d, Full regulatory cascade example at BACH2, showing rs72928038 regulating chromatin accessibility at peak i (c, enhancer; chr6:90266796-90267690), which exhibits significant co-accessibility with peak ii (d, promoter; chr6:90295895-90296663). Normalized chromatin accessibility (CA; sequence coverage) is normalized per one million fragments. Colour represents the number of alternative alleles of rs72928038, which is in near-complete linkage disequilibrium with rs6908626 (r2 = 0.99). Points shown at the bottom as a diamond represent the locations of rs72928038 and rs6908626 at the BACH2 locus, respectively. e, Cell type specificity distribution across the QTL mechanism categories. Colour and text represent the fraction for each category.
Extended Data Fig. 6 Massively parallel reporter assay (MPRA) validation of fine-mapped molQTL variants and CASCADE mechanism categories.
a,b, Fraction of expression-modulating variants (emVars) among molQTL variants, stratified by maximum PIP bins across cell types and genes for cis-eQTL (red) and cis-caQTL (blue), in K562 (a) and meta-analysis across five cell lines (b; Methods). The “Null” bin comprises control variants from ref. 7. c,d, Spearman rank correlation (ρ) between MPRA allelic effects (Δlog2 FC) and molQTL effect sizes (β), computed among emVars and stratified by maximum PIP bin and QTL type, in K562 (c) and meta-analysis (d). e,f, Fraction of emVars across CASCADE mechanism categories among fine-mapped molQTL variants (PIP > 0.5), in K562 (e) and meta-analysis (f). The number of emVars out of total MPRA-tested variants is annotated per category. Error bars represent 95% confidence intervals.
Extended Data Fig. 7 Regulatory cascade variants for autoimmune hypothyroidism.
LocusZoom plots of cascade variants at TICAM1 (a), RHOH (b), and RNASET2 (c) loci, colocalizing with autoimmune hypothyroidism (AIHT). For each locus, the top panel represents a LocusZoom plot of AIHT GWAS in FinnGen. The middle panel represents cis-eQTL associations of individual genes in our dataset. All P values are two-sided. The bottom panel represents peak–gene links between chromatin accessibility peaks and gene expression across cell types (hurdle model, FDR < 0.05). Each curved line represents a link, where the bold line represents peaks involved in the cascade mechanisms. Colour represents effect sizes of peak–gene links, and the y axis shows the corresponding absolute value. Marginal rugs at the top represent CA peak locations. Linked peak locations are highlighted as a grey area across panels: chr19:4837478-4837977 at TICAM1 (a), chr4:40258141-40259058 at RHOH (b), and chr6:166950262-166950954 at RNASET2 (c) loci.
Extended Data Fig. 8 Regulatory cascade mechanisms underlying diseases in non-blood tissues.
LocusZoom plots of PILRB (a), TYROBP (b), and APOBEC3A/CBX6 (c) loci, colocalizing with Alzheimer’s disease (a,b) and breast cancer (c). For each locus, the top panel represents a LocusZoom plot of GWAS summary statistics for each disease. The middle panel represents cis-eQTL associations of individual genes in our dataset. All P values are two-sided. The bottom panel (except for b) represents peak–gene links between chromatin accessibility peaks and gene expression across cell types (hurdle model, FDR < 0.05). Each curved line represents a link, where the bold line represents peaks involved in the cascade mechanisms. Colour represents effect sizes of peak–gene links, and the y axis shows the corresponding absolute value. Marginal rugs at the top represent CA peak locations. The linked peak location (chr7:100295229-100295728) at the PILRB locus (a) is highlighted as a grey area across panels.
Extended Data Fig. 9 Multi-layered regulatory buffering at constrained genes.
a, The relationship between the fraction of genes with eQTL or linked peaks affected by caQTL and loss-of-function observed/expected upper bound fraction (LOEUF) deciles. b, The median of normalized mean expression (count-per-ten-thousand, CP10K) across LOEUF deciles, computed for all genes and expression-matched highly expressed (top 20%) genes across the deciles. c, The median of expression variance residuals, corrected by mean expression, across LOEUF deciles (Methods). d, Median absolute cis-eQTL effect sizes (|βeQTL|) across LOEUF deciles for expression-matched (top 20%) and expression-and-variance-matched gene subsets. e, Median |βeQTL| across LOEUF deciles in pseudobulk PBMC using tensorQTL, comparing rank-based inverse normal transformation (RINT) and log2(CP10K + 1) normalization strategies (Methods). f,g, The median MAF-normalized absolute effect sizes for cis-eQTLs (f) and cis-caQTLs (g). Colour represents the fraction of genes with either eQTL (red) or linked peaks affected by caQTL (blue) for each decile. h–j, Median number of linked peaks per gene (h), median absolute peak–gene link effect sizes (|βlink|; i), and median absolute peak–gene distance to transcription start site (TSS; j) across LOEUF deciles, stratified by peak regulatory mode (dual, switch, rheostat). k, The distribution of median genomic non-coding constraint of haploinsufficient variation (Gnocchi), computed for most constrained, strongest effect, or randomly selected peaks. l, The median absolute link effect sizes, stratified by both peak and gene constraints. LOEUF quintiles, not deciles, were used to account for a limited number of genes (Methods). Gnocchi threshold of 4 was used to group constrained and unconstrained peaks. Error bars (and shaded ribbons) represent 95% confidence intervals.
Extended Data Fig. 10 The buffering gradient is independent of intrinsic cis-regulatory activity and cellular stimulation.
a, Median absolute cis-eQTL effect size (|βeQTL|) across LOEUF quintiles in iPSC-derived macrophages from ref. 42, stratified by stimulation conditions (Methods). Shaded ribbons represent 95% confidence intervals. b, Median maximum absolute cis-caQTL effect size (|βcaQTL|) per gene across LOEUF quintiles, stratified by stimulation condition. c,d, Fraction of emVars among fine-mapped molQTL variants (PIP > 0.5), stratified by the LOEUF quintile of the target gene, in K562 (c) and meta-analysis (d). e,f, Median absolute MPRA allelic effect (|Δlog2 FC|) of fine-mapped molQTL variants across LOEUF quintiles of the target gene, K562 (e) and meta-analysis (f). Shaded ribbons represent 95% confidence intervals of the median.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kanai, M., Delorey, T.M., Honkanen, J. et al. Population-scale immune multiome atlas reveals regulatory disease mechanisms. Nature (2026). https://doi.org/10.1038/s41586-026-11078-2
Received: 13 November 2025
Accepted: 25 August 2026
Published: 30 September 2026
Version of record: 30 September 2026
DOI: https://doi.org/10.1038/s41586-026-11078-2
来源:Nature 综合主刊 · nature.com